摘要
背景:糖尿病(DM)是一个全球性的健康问题,以胰岛素分泌不足或胰岛素活性失败导致的高血糖为特征。迫切需要发现替代的治疗药物,以克服目前合成的抗糖尿病药物的缺点。 目的:本文综述了2014年至2019年最近发表的已知和新型天然化合物、生物碱、黄酮和具有强大的皂苷活性的报道。我们讨论了将这些化合物纳入有效的抗糖尿病候选药物的潜在作用机制。 方法:信息来源于谷歌学者、Scirus、PubMed和科学直接网站。 讨论与结论:报道的天然化合物通过抑制α-淀粉酶、α-葡萄糖苷酶、胰岛素致敏作用、直接作用于蛋白酪氨酸磷酸酶1B(PTP1B)、P过氧化物酶体增殖物活化受体(PPARs)、GLUT4表达、胰岛素受体底物-1(IRS-1)和糖原合酶激酶-3β(GSK-3β)以及二肽基肽酶-4(DPP-4)等不同机制表现出良好的抗糖尿病活性。一些化合物抑制了晚期糖基化终末产物(AGEs)的形成。其他化合物可以预防糖尿病并发症的风险,如心血管疾病、视网膜病变和肾病。这篇综述提供了一个关键的概述,最新发现的抗糖尿病药物从天然来源。这一概述可以帮助研究人员关注最突出的候选者,旨在开发新的药物线索。
关键词: 尿病、胰岛素、高血糖、天然化合物、作用机制、抗糖尿病等
Current Medicinal Chemistry
Title:The Role of Plant-Derived Compounds in Managing Diabetes Mellitus: A Review of Literature from 2014 To 2019
Volume: 28 Issue: 23
关键词: 尿病、胰岛素、高血糖、天然化合物、作用机制、抗糖尿病等
摘要:
Background: Diabetes mellitus (DM) represents a global health problem characterized by hyperglycemia due to insufficient insulin secretion or failure of insulin activity. There is an imperative need for the discovery of alternative therapeutic agents that overcome the drawbacks of the current synthetic antidiabetic drugs.
Objectives: This review critically summarizes the reports on the known and novel natural compounds, including alkaloids, flavonoids, and saponins with a potent antidiabetic activity that were recently published from 2014 to 2019. We discussed the underlying mechanisms of action that put these compounds in the category of effective antidiabetic candidates.
Methods: Information was obtained from Google Scholar, Scirus, PubMed, and Science Direct.
Discussion and Conclusion: The reported natural compounds showed promising antidiabetic activity through different mechanisms such as the inhibition of α-amylase, α-glucosidase, insulin-sensitizing effect, direct action on protein tyrosine phosphatase 1B (PTP1B), peroxisome proliferator-activated receptors (PPARs), GLUT4 expression, insulin receptor substrate-1 (IRS-1) and glycogen synthase kinase-3β (GSK-3β) as well as dipeptidyl peptidase-4 (DPP-4) enzyme. Some compounds inhibited the formation of advanced glycation end products (AGEs). Other compounds prevented the risk of diabetic complications such as cardiovascular diseases, retinopathy, and nephropathy. This review provides a critical overview of the most recent discoveries of antidiabetic agents from natural sources. This overview could help researchers to focus on the most prominent candidates aiming to develop new drug leads.
Export Options
About this article
Cite this article as:
The Role of Plant-Derived Compounds in Managing Diabetes Mellitus: A Review of Literature from 2014 To 2019, Current Medicinal Chemistry 2021; 28 (23) . https://dx.doi.org/10.2174/0929867328999201123194510
DOI https://dx.doi.org/10.2174/0929867328999201123194510 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Pathophysiology of Blood-Brain Barrier in Brain Injury in Cold and Hot Environments: Novel Drug Targets for Neuroprotection
CNS & Neurological Disorders - Drug Targets Screening and Identification of Differentially Expressed Genes Between Diabetic Nephropathy Glomerular and Normal Glomerular via Bioinformatics Technology
Combinatorial Chemistry & High Throughput Screening Ezetimibe Therapy for Dyslipidemia: An Update
Current Pharmaceutical Design Editorial [Hot topic: Transportalopathy and Vascular Cell Dysfunction (Guest Editor: Luis Sobrevia)]
Current Vascular Pharmacology Role of Hydrogen Sulfide in Systemic and Pulmonary Hypertension: Cellular Mechanisms and Therapeutic Implications
Cardiovascular & Hematological Agents in Medicinal Chemistry Endothelial Progenitor Cells and Vascular Biology in Diabetes Mellitus: Current Knowledge and Future Perspectives
Current Diabetes Reviews Common Drugs for Stabilization of Renal Function in the Progression of Diabetic Nephropathy and Their Relations with Hypertension Therapy
Current Diabetes Reviews Synthesis, Structural Characterization and Docking Studies of Sulfamoyl- Phenyl Acid Esters as Dipeptidyl Peptidase-IV Inhibitors
Current Computer-Aided Drug Design Leptin and the Cardiovascular System: A Review
Recent Patents on Cardiovascular Drug Discovery Fibrates and Microvascular Complications in Diabetes - Insight from the FIELD Study
Current Pharmaceutical Design Apolipoprotein E Knockout Models
Current Pharmaceutical Design Arterial Stiffness and Type 1 Diabetes: The Current State of Knowledge
Current Diabetes Reviews Preventive and Therapeutic Potentials of Anthocyanins in Diabetes and Associated Complications
Current Medicinal Chemistry Pharma-metabolomics in Neonatology: is it a Dream or a Fact?
Current Pharmaceutical Design Complications of Anti-Vascular Endothelial Growth Factor Drugs
Current Drug Therapy A Clinical Decision Support System for Assessing the Risk of Cardiovascular Diseases in Diabetic Hemodialysis Patients
Current Diabetes Reviews Recommendations for the Treatment of Hypertension in Elderly People
Cardiovascular & Hematological Agents in Medicinal Chemistry The Effect of Dual-Task Testing on Balance and Gait Performance in Adults with Type 1 or Type 2 Diabetes Mellitus: A Systematic Review
Current Diabetes Reviews Effects of Highly Active Antiretroviral Therapy on Albuminuria in HIV-infected Persons
Infectious Disorders - Drug Targets Anthocyanins as a Potential Therapy for Diabetic Retinopathy
Current Medicinal Chemistry